XRP ETFs Log Ninth Straight Day of Inflows
U.S.-listed XRP ETFs recorded a ninth straight day of net inflows, bringing total inflows to $1.6 billion since their launch.
U.S.-listed exchange-traded funds tied to XRP recorded net inflows for a ninth consecutive day, taking cumulative intake to $1.6 billion since the funds began trading. The inflows consisted of daily net purchases rather than single large subscriptions.
Over the nine-day period, investors used ETF wrappers to gain exposure to XRP without buying and storing the token directly. The funds trade on U.S. exchanges during market hours and are available through brokerage accounts and retirement plans that accept ETFs.
Fund sponsors manage custody, settlement and regulatory disclosures. Depending on each fund’s structure, sponsors either hold underlying XRP in third-party custody or use derivatives to replicate token performance.
Market participants pointed to familiar ETF structures, broker-dealer access and third-party custody arrangements as reasons some accounts prefer ETFs to direct token holdings. Trading volumes in the ETFs have supported intra-day price discovery for investors adjusting allocations.
XRP is the native token associated with Ripple Labs and is used in digital payment and settlement applications. The token has faced legal and regulatory scrutiny in the past; the ETF structure gives investors a regulated route to exposure within conventional financial accounts.
Asset managers and advisers are tracking ongoing flows to assess demand and liquidity as the products settle into regular trading patterns.
The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.








